TR200200631T2 - Alfa-2/Delta geni - Google Patents
Alfa-2/Delta geniInfo
- Publication number
- TR200200631T2 TR200200631T2 TR2002/00631T TR200200631T TR200200631T2 TR 200200631 T2 TR200200631 T2 TR 200200631T2 TR 2002/00631 T TR2002/00631 T TR 2002/00631T TR 200200631 T TR200200631 T TR 200200631T TR 200200631 T2 TR200200631 T2 TR 200200631T2
- Authority
- TR
- Turkey
- Prior art keywords
- alpha
- genes
- gene
- delta gene
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Bu bulus, üç yeni gene ve bu genlerden türetilen, bir çok kalsiyum kanalinda bir alt-birim halinde varolan ''alfa2S-C'2 ve/veya ''alfa2SD'' proteinlerini kodlayan polipeptidlere iliskindir. Bulus, ayni zamanda, yeni gen ve polipeptidlerin, genin genetik silinmelerinin bulgulanmasinda, polipeptidin subselüler konumlanisinda kimyasal veri tabanlari ile baglantili baglanma tahlillerinde, gen terapisinde kullanilmasi için yöntemleri de anlatmaktadir.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10332298P | 1998-10-07 | 1998-10-07 | |
US10647398P | 1998-10-30 | 1998-10-30 | |
US11408898P | 1998-12-29 | 1998-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200200631T2 true TR200200631T2 (tr) | 2002-06-21 |
Family
ID=27379516
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00937T TR200100937T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/Delta geni |
TR2002/00631T TR200200631T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/Delta geni |
TR2002/00632T TR200200632T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/Delta Geni |
TR2002/00571T TR200200571T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/delta geni |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00937T TR200100937T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/Delta geni |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00632T TR200200632T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/Delta Geni |
TR2002/00571T TR200200571T2 (tr) | 1998-10-07 | 1999-10-07 | Alfa-2/delta geni |
Country Status (7)
Country | Link |
---|---|
US (1) | US7262052B1 (tr) |
EP (1) | EP1117796A2 (tr) |
JP (1) | JP2002526100A (tr) |
AU (1) | AU1106500A (tr) |
CA (1) | CA2341351A1 (tr) |
TR (4) | TR200100937T2 (tr) |
WO (1) | WO2000020450A2 (tr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783952B1 (en) * | 1999-09-16 | 2004-08-31 | Warner-Lambert Company | Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same |
US6962973B1 (en) | 1999-09-16 | 2005-11-08 | Warner-Lambert Company | Porcine α2δ-1 calcium channel subunit cDNA and soluble secreted α2δ-1 subunit polypeptides |
CA2384911C (en) | 1999-09-16 | 2008-07-22 | Warner-Lambert Company | Method for the screening of .alpha.2. delta.-1 subunit binding ligands |
AU2001255448A1 (en) | 2000-04-17 | 2001-10-30 | Stephen B. Liggett | Alpha-2 adrenergic receptor polymorphisms |
US20020081657A1 (en) * | 2000-06-05 | 2002-06-27 | Curtis Rory A.J. | 21784, a novel human calcium channel family member and uses thereof |
US7294691B1 (en) | 2000-09-18 | 2007-11-13 | Warner Lambert Company | Soluble secreted α2δ-2calcium channel subunit polypeptide |
US7524643B2 (en) | 2001-04-11 | 2009-04-28 | Ortho-Mcneil Pharmaceutical, Inc. | CDNA encoding the human alpha2 delta4 calcium channel subunit |
US7049084B2 (en) * | 2001-05-30 | 2006-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore |
CA2581086C (en) | 2004-09-14 | 2023-11-07 | The Regents Of The University Of Colorado, A Body Corporate | Method for treatment with bucindolol based on genetic targeting |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874236A (en) * | 1988-04-04 | 1999-02-23 | Sibia Neurosciences. Inc. | DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits |
US6040436A (en) * | 1996-09-16 | 2000-03-21 | American Home Products Corporation | Nucleic acid encoding human neuronal calcium channel subunits |
WO2000012711A2 (en) * | 1998-09-02 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Human membrane channel proteins |
-
1999
- 1999-10-07 TR TR2001/00937T patent/TR200100937T2/tr unknown
- 1999-10-07 TR TR2002/00631T patent/TR200200631T2/tr unknown
- 1999-10-07 CA CA002341351A patent/CA2341351A1/en not_active Abandoned
- 1999-10-07 US US09/787,657 patent/US7262052B1/en not_active Expired - Fee Related
- 1999-10-07 TR TR2002/00632T patent/TR200200632T2/tr unknown
- 1999-10-07 WO PCT/US1999/023519 patent/WO2000020450A2/en active Application Filing
- 1999-10-07 AU AU11065/00A patent/AU1106500A/en not_active Abandoned
- 1999-10-07 JP JP2000574561A patent/JP2002526100A/ja not_active Abandoned
- 1999-10-07 TR TR2002/00571T patent/TR200200571T2/tr unknown
- 1999-10-07 EP EP99954806A patent/EP1117796A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TR200200571T2 (tr) | 2002-06-21 |
CA2341351A1 (en) | 2000-04-13 |
JP2002526100A (ja) | 2002-08-20 |
TR200100937T2 (tr) | 2001-10-22 |
TR200200632T2 (tr) | 2002-07-22 |
EP1117796A2 (en) | 2001-07-25 |
WO2000020450A9 (en) | 2001-04-05 |
AU1106500A (en) | 2000-04-26 |
WO2000020450A2 (en) | 2000-04-13 |
US7262052B1 (en) | 2007-08-28 |
WO2000020450A3 (en) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
NO2011003I1 (no) | Dimensk fusjonsprotein bestående av de ligandbindende cfomener av de ekstacellulære deler av human type I interieukm-1 reseptor (IL-1R1) og IL-1 reseptor hjelpeprotein bundet (IL-I-RAcP) bundet i tinje til Fc-delen av humant IgG | |
IL193886A (en) | Antibodies that bind to ldcam sequences | |
TR200200631T2 (tr) | Alfa-2/Delta geni | |
GR3019849T3 (en) | Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis | |
PT973794E (pt) | Receptores de netrina | |
EP1005539A4 (en) | IKK-ALPHA PROTEINS, NUCLEIC ACIDS AND METHOD | |
ATE350472T1 (de) | Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen | |
ATE310085T1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
DK1009817T3 (da) | RTD-receptor | |
TR199900277T2 (tr) | Nematodlara ve/veya yaprak bitlerine karsi direnç. | |
WO2002066640A3 (en) | Zinc finger binding domains for nucleotide sequence ann | |
TR200000416T2 (tr) | Neisseria loctoferrin bağlayıcı protein. | |
DE60119552D1 (de) | Isolierte peptide, die an hla-c moleküle binden und deren verwendung | |
FR2697850B1 (fr) | Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations. | |
IL153833A0 (en) | Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches | |
CA2311646A1 (en) | Tsa305 gene | |
DE69733026D1 (de) | Cyclin e spezifische konstrukte und komplexe | |
DE69933444D1 (de) | Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen | |
TW342413B (en) | Novel toxins isolated from Bracon Hebetor | |
ATE348109T1 (de) | Das gen prv-1 und dessen verwendung | |
ATE332373T1 (de) | Menschlisches il-1 epsilon dna und polypeptide | |
ATE275207T1 (de) | Dna zur abschätzung des progressionspotentials von zervixläsionen | |
WO2000008178A3 (en) | Murine dna molecules encoding polypeptides having kinase functions |